Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.

Provoost A, Dramé M, Cotte L, Cuzin L, Garraffo R, Rey D, Raffi F, Poizot-Martin I, Pugliese P, Bani-Sadr F; Dat'AIDS study group.

Aliment Pharmacol Ther. 2018 Jun 14. doi: 10.1111/apt.14812. [Epub ahead of print]

PMID:
29901821
2.

Frail and pre-frail phenotype is associated with pain in older HIV-infected patients.

Petit N, Enel P, Ravaux I, Darque A, Baumstarck K, Bregigeon S, Retornaz F; Visage group.

Medicine (Baltimore). 2018 Feb;97(6):e9852. doi: 10.1097/MD.0000000000009852.

3.

Reservoir Computing Properties of Neural Dynamics in Prefrontal Cortex.

Enel P, Procyk E, Quilodran R, Dominey PF.

PLoS Comput Biol. 2016 Jun 10;12(6):e1004967. doi: 10.1371/journal.pcbi.1004967. eCollection 2016 Jun.

4.

Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load.

Flandre P, Pugliese P, Allavena C, Katlama C, Cotte L, Cheret A, Cabié A, Rey D, Chirouze C, Bani-Sadr F, Cuzin L; Dat'AIDS Study group.

HIV Med. 2016 May;17(5):380-4. doi: 10.1111/hiv.12306. Epub 2015 Aug 26.

5.

Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease.

Hentzien M, Dramé M, Allavena C, Jacomet C, Valantin MA, Cabié A, Cuzin L, Rey D, Pugliese P, Bani-Sadr F; Dat'AIDS Study Group.

J Nutr Health Aging. 2016 Apr;20(4):408-14. doi: 10.1007/s12603-015-0608-7.

PMID:
26999241
6.

Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.

Potard V, Reynes J, Ferry T, Aubin C, Finkielsztejn L, Yazdanpanah Y, Costagliola D; FHDH ANRS CO4.

PLoS One. 2015 Dec 29;10(12):e0144746. doi: 10.1371/journal.pone.0144746. eCollection 2015.

7.

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach.

Cuzin L, Pugliese P, Allavena C, Katlama C, Cotte L, Cheret A, Cabié A, Rey D, Chirouze C, Bani-Sadr F, Flandre P; Dat'AIDS Study group.

Medicine (Baltimore). 2015 Sep;94(39):e1668. doi: 10.1097/MD.0000000000001668.

8.

Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.

Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration.

Lancet HIV. 2015 Aug;2(8):e335-43. doi: 10.1016/S2352-3018(15)00108-3. Epub 2015 Jul 7.

9.

A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial.

Abgrall S, Rachas A, Tourret J, Isnard-Bagnis C, Billaud E, Tattevin P, Costagliola D, Guiguet M, Durieux P; French Hospital Database on HIV.

Clin Infect Dis. 2015 Aug 1;61(3):375-84. doi: 10.1093/cid/civ310. Epub 2015 Apr 22.

PMID:
25904366
10.

Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.

de Monteynard LA, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Gilquin J, Rey D, Simon A, Pavie J, Mahamat A, Matheron S, Costagliola D, Abgrall S; French Hospital Database on HIV.

PLoS One. 2015 Mar 3;10(3):e0118492. doi: 10.1371/journal.pone.0118492. eCollection 2015.

11.

Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.

Grabar S, Tattevin P, Selinger-Leneman H, de La Blanchardiere A, de Truchis P, Rabaud C, Rey D, Daneluzzi V, Ferret S, Lascaux AS, Hanslik T, Costagliola D, Launay O; French Hospital Database on HIV (FHDH-ANRS CO4 Cohort).

Clin Infect Dis. 2015 Apr 15;60(8):1269-77. doi: 10.1093/cid/ciu1161. Epub 2015 Jan 18.

12.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6.

13.

Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access.

Delaugerre C, Ghosn J, Lacombe JM, Pialoux G, Cuzin L, Launay O, Menard A, de Truchis P, Costagliola D; FHDH-ANRS CO4.

Clin Infect Dis. 2015 Feb 1;60(3):463-72. doi: 10.1093/cid/ciu834. Epub 2014 Oct 23.

PMID:
25344539
14.

Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.

Hleyhel M, Hleyhel M, Bouvier AM, Belot A, Tattevin P, Pacanowski J, Genet P, De Castro N, Berger JL, Dupont C, Lavolé A, Pradier C, Salmon D, Simon A, Martinez V, Spano JP, Costagliola D, Grabar S; Cancer Risk Group of the French Hospital Database on HIV (FHDH-ANRS CO4).

AIDS. 2014 Sep 10;28(14):2109-18. doi: 10.1097/QAD.0000000000000382.

PMID:
25265077
15.

Behavioral Regulation and the Modulation of Information Coding in the Lateral Prefrontal and Cingulate Cortex.

Khamassi M, Quilodran R, Enel P, Dominey PF, Procyk E.

Cereb Cortex. 2015 Sep;25(9):3197-218. doi: 10.1093/cercor/bhu114. Epub 2014 Jun 5.

PMID:
24904073
16.

Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4).

Mary-Krause M, Grabar S, Lièvre L, Abgrall S, Billaud E, Boué F, Boyer L, Cabié A, Cotte L, De Truchis P, Duval X, Duvivier C, Enel P, Gasnault J, Gaud C, Gilquin J, Guiguet M, Katlama C, Khuong-Josses MA, Lacombe JM, Lang S, Lascaux AS, Launay O, Mahamat A, Matheron S, Meynard JL, Pavie J, Pilorgé F, Piroth L, Poizot-Martin I, Potard V, Pradier C, Reynes J, Rouveix E, Selinger-Leneman H, Simon A, Tattevin P, Tissot-Dupont H, Viard JP, Viget N, Costagliola D.

Int J Epidemiol. 2014 Oct;43(5):1425-36. doi: 10.1093/ije/dyu002. Epub 2014 Feb 17.

PMID:
24550249
17.

Incidences and risk factors of first-line HAART discontinuation: a limitation to the success of the "seek, test, treat, and retain" strategy?

Keita M, Perbost I, Pugliese-Wehrlen S, Abel S, Pugliese P, Enel P, Cuzin L, Lang T, Delpierre C; Dat'AIDS Group.

AIDS Care. 2014;26(8):1058-69. doi: 10.1080/09540121.2014.882490. Epub 2014 Feb 11.

PMID:
24517736
18.

Comparison of classifiers for decoding sensory and cognitive information from prefrontal neuronal populations.

Astrand E, Enel P, Ibos G, Dominey PF, Baraduc P, Ben Hamed S.

PLoS One. 2014 Jan 23;9(1):e86314. doi: 10.1371/journal.pone.0086314. eCollection 2014.

19.

Can the "seek, test, treat, and retain" strategy be effective in France?

Cuzin L, Allavena C, Pugliese P, Rey D, Hoen B, Poizot-Martin I, Cabie A, Yazdanpanah Y; DATʼAIDS Study Group.

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):e119-21. doi: 10.1097/QAI.0b013e3182809f08. No abstract available.

PMID:
23933718
20.

[Patient education: state of the art of the programs in the region of Provence-Alpes-Côte d'Azur in 2008 before the publication of official documents relative to the authorizations of the Regional Health Agency (ARS)].

Parron S, Gentile S, Enel P, Benhaïm L, Ferrandino J, Bentz L, Sambuc R.

Rev Epidemiol Sante Publique. 2013 Feb;61(1):57-65. doi: 10.1016/j.respe.2012.06.403. Epub 2013 Jan 29. French.

PMID:
23374985

Supplemental Content

Loading ...
Support Center